ONESOURCE Share Price Target 2035

CAGR-based price projection for Onesource Specialty Pharma Limited (ONESOURCE) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (1.9% CAGR)
Rs 1,790
2035 Target
Base Case (4.8% CAGR)
Rs 2,300
2035 Target
Bull Case (12.8% CAGR)
Rs 4,453
2035 Target

Current Market Snapshot

CMP: Rs 1,508.00
52W High: Rs 1,867.40
52W Low: Rs 1,438.90
1Y CAGR: 9.8%
3Y CAGR: 4.8%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,537 Rs 1,580 Rs 1,701
2028 Rs 1,566 Rs 1,656 Rs 1,918
2029 Rs 1,597 Rs 1,736 Rs 2,164
2030 Rs 1,627 Rs 1,819 Rs 2,440
2031 Rs 1,659 Rs 1,907 Rs 2,752
2032 Rs 1,690 Rs 1,998 Rs 3,104
2033 Rs 1,723 Rs 2,094 Rs 3,501
2034 Rs 1,756 Rs 2,195 Rs 3,949
2035 Rs 1,790 Rs 2,300 Rs 4,453

Other ONESOURCE Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the ONESOURCE share price target for 2035?

Based on historical growth analysis, the ONESOURCE share price target for 2035 ranges from Rs 1,790 (conservative) to Rs 2,300 (base case) to Rs 4,453 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of ONESOURCE?

The current market price of ONESOURCE (Onesource Specialty Pharma Limited) is Rs 1,508.00. The 52-week high is Rs 1,867.40 and 52-week low is Rs 1,438.90.

Is ONESOURCE a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for ONESOURCE price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 1.9% CAGR), Base (4.8% CAGR), and Bull (optimistic at 12.8% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.